IDH1 inhibitors are used for the treatment of leukemia. They work by inhibiting the production of certain acids in your body that can affect white blood cells.
IDH1 inhibitors are used to treat acute myeloid leukemia (AML), cholangiocarcinoma (bile duct cancer), and myelodysplastic syndromes. These medications work by targeting and inhibiting mutated isocitrate dehydrogenase-1 (IDH1) enzymes, which helps to slow the growth of cancer cells. IDH1 inhibitors are available in oral form, making them convenient to take. Examples include Tibsovo (ivosidenib) and Rezlidhia (olutasidenib).
Voranigo is part of the IDH1 Inhibitors class and treats Brain Tumor. IDH1 inhibitors are used for the treatment of leukemia. They work by inhibiting the production of certain acids in your body that can affect white blood cells. Voranigo is only available as a brand name drug.
OLUTASIDENIB treats leukemia. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
IVOSIDENIB treats bile duct cancer. It may also be used to treat blood and bone marrow cancers. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up
